Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...

The elderly man has been admitted to the hospital on Wednesday and his samples tested positive for HMPV on Thursday. The man ...

In China, reports of HMPV infections have indeed been rising in recent weeks in the more northerly regions. But so have ...

The UK Health Security Agency has issued an update as the NHS is facing huge pressure from people falling seriously ill with ...

An 80-year-old man tested positive for human metapneumovirus (HMPV) infection in Ahmedabad city of Gujarat on Thursday, ...

Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.

Hospital leaders expect case volume of flu, the common cold, and respiratory syncytial virus, RSV, to keep climbing.

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.

Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...

The Centers for Disease Control and Prevention (CDC) is reporting a significant increase in respiratory illnesses nationwide, ...